s6y

Medline Inc.

Ticker
MDLN
CIK
2046386
Industry
Surgical & Medical Instruments & Apparatus

Financials 4

  1. 10-Q Quarterly Report for period ending Sep 26, 2026
  2. 10-Q Quarterly Report for period ending Jun 27, 2026
  3. 10-Q Quarterly Report for period ending Mar 28, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025

News 11

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 11 news filings

Ownership 109

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 109 ownership filings

Prospectus 22

  1. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  4. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  5. S-1MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  8. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 22 prospectus filings

Proxies 2

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements

Other 30

  1. EFFECT Notice of Effectiveness
  2. 144/A Filing for proposed sale of securities under Rule 144
  3. 144 Filing for proposed sale of securities under Rule 144
  4. SCHEDULE 13G
  5. SCHEDULE 13G/A
  6. SCHEDULE 13G/A
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G/A
  9. SCHEDULE 13G
  10. 144 Filing for proposed sale of securities under Rule 144

All 30 other filings